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With cardiovascular diseases representing 
a leading cause of death worldwide, several 
biological aspects of heart physiology and 
pathology remain open and therapeutic needs 
widely unmet. The attention of biomedi-
cal research has been directed toward the 
development and exploitation of meaningful 
in vitro models of the myocardium, in both 
health and disease. Indeed, an increasing 
need has risen for advanced platforms able 
to investigate heart pathological mechanisms 
or development of drug treatments with low 
impact on cardiac function.
An ideal in vitro heart model should be 
capable of tailoring environmental cues pro-
vided to human cells or tissues (biochemi-
cal signals, physical stimulations) while also 
providing means to analyze functional read-
outs (e.g., contractility of the tissue, electri-
cal activity). These specifics are the key to 
conduct both basic research investigations 
(e.g., cellular mechanisms of cardiac pathol-
ogies) and translational studies (effects of 
candidate drug compounds on heart func-
tions). A class of culture platforms recently 
acknowledged as prospective to meet these 
needs and advance these fields are organs-
on-chips.
Exploiting photo and soft-lithography 
microfabrication techniques, organs-on-
chip provide microstructured arrangements 
of cells recapitulating key organ/tissue func-
tions and supplied by microfluidic chan-
nels [1]. The relatively low volume of fluids 
required to culture cells within these devices 
makes it possible to focus the use of organs-
on-chip toward human cells (primary cells 
or derived from pluripotent stem cells), thus 
stepping away from animal sources. These 
concepts have been applied to heart-derived 
cells in order to more finely recapitulate 
the cardiac environment in vitro within so-
called heart-on-chips. To date, this rapidly 
growing field accounts for several reports 
describing heart-on-chip designs [2], which 
in some instances were validated for carry-
ing out relevant drug screening studies [3]. 
Heart-on-chip models therefore hold con-
crete potential for advancing the field of 
cell culture platform. However, they still 
require improvements and directions in 
order to attain meaningful biological mod-
els for robustly serving pharmaceutical 
screenings or basic research. We here com-
ment on existing heart-on-chip microfluidic 
devices, with an outlook on unmet require-
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ments and future directions for rational technological 
 development.
Controlling physical & chemical 
environments
An inherent advantage of microfabricated organs-on-
chip is the ability of applying tailored physical and/
or biochemical cues to cultured cells, in an attempt to 
more closely mimic the cardiac cellular microenviron-
ment. A prominent physical stimulus in the heart is 
the cyclic mechanical loading caused by tissue contrac-
tility. The mechanical microenvironment is known 
to have major effects on cardiac cells and has been 
shown to drive cellular fate of several heart-related cell 
types [4].
A substantial number of investigations regarding 
mechanical loading platforms and biological cellular 
responses have been carried out by means of microflu-
idic systems. Flexible substrates allow to culture cellular 
monolayers and on-chip pneumatic actuation systems 
typically provide pressure or vacuum-driven substrate 
stretching. This class of microsystems led to signifi-
cant developments in the exploration of cardiac cells 
mechano-responses: embryonic stem cells were shown 
to exhibit a preferential cardiomyogenic differentiation 
when subjected to cyclic mechanical stimuli [5]. In the 
field of fibrotic response, human cardiac fibroblasts 
were shown to exhibit different responses according 
to the intensity of mechanical stimuli applied [6,7]. 
Cardiac myocytes 3D constructs exhibited synchro-
nous contraction only under mechanical stimulation, 
with unorganized patterns of contraction in the non-
stimulated counterparts [8]. Of note, recent technical 
developments include a design solution for coupling 
3D hydrogel-based constructs with cyclic mechanical 
stimulation in microfluidics [8], thus enabling the fab-
rication of organs-on-chip that combine the physiolog-
ical architecture of 3D ECM-based constructs with the 
possibility of mechanically stimulate them.
Electrical stimulation is another key feature repro-
duced in vitro to better recapitulate the in vivo cardiac 
environment. In the heart, cardiac cells are electrically 
coupled and continuously subjected to electric currents. 
Biomimetic electric signals have been demonstrated to 
enhance conductive and contractile properties of car-
diomyocytes and to influence stem cell fate [9]. Several 
microfluidic platforms have been developed to provide 
cells with different electrical stimulation patterns, 
applied alone or in concert with other stimulations 
(i.e., chemical, mechanical, topological). 2D flat elec-
trodes obtained through electrodeposition [10] or laser 
ablation [11] technologies can be directly integrated in 
microfluidic platform surfaces, where cellular mono-
layers are cultured. Alternatively, 3D electrodes can be 
formed by injecting conductive compounds in a pre-
designed compartment of the platform [12] or can be 
achieved directly inserting physical electrodes (plati-
num wires, carbon rods, stainless steel) in contact with 
cell culture medium.
Electric fields applied on cardiomyocytes monolay-
ers successfully provided appropriate environmental 
cues to maintain cardiac phenotype and contractile 
function in vitro, enhancing cellular elongation, car-
diac maturation, beating performances and gap junc-
tion organization [11]. In heart-on-chip systems hous-
ing 3D cell-laden hydrogels, electrical stimulation 
allowed, for instance, human pluripotent stem cells [13] 
derived cardiomyocytes to mature in a tissue-like con-
structs, enhancing construct organization and conduc-
tion velocity.
Standard systems for cardiac functional 
readouts
While microenvironmental cues are key factors for 
aiding cardiac constructs maturation and mimicking 
physiological or pathological states, another crucial 
aspect in designing heart-on-chip devices is the inclu-
sion of readout systems for assessing cardiac biological 
functions. Contractility is the hallmark of heart func-
tion and contractile force quantification is one of the 
most important functional characterizations of cardiac 
muscle. Over the past decades, enormous efforts have 
been made to develop techniques that overcome the 
challenges in assessing the contractile properties of car-
diomyocytes. Huebsch et al. [14] adopted a force trans-
ducer system technique to assess microheart muscle 
physiology. This technique required harsh manipula-
tions of the tissue: microheart muscles were microdis-
sected, removed from its original platform, hooked 
and immersed in a bath. Although, often used two-
point force assays measure force along a single axis, 
neglecting multidirectional contraction exerted by 
cells whose cytoskeleton is unaligned (e.g., immature 
 cardiomyocytes).
Some appealing, noninvasive approaches for force 
measurement are based on small cantilever deflections. 
In atomic force microscopy, a small cantilever gently 
touches a beating cardiomyocyte and its vertical deflec-
tion tracks the beating force signal [15]. Nonetheless, 
atomic force microscopy instrumentation has a low 
chance of being integrated in compact systems. In a 
pivotal work, Tanaka et al. [16] demonstrated a cheaper 
solution to measure single-cell contractile force, by 
using polydimethylsiloxane(PDMS)-based arrays of 
micropillars that deflect according to the motion of 
attached cardiomyocytes. Their strategy requires video 
analysis and mathematical estimations that depend on 
pillar shape and on cardiomyocytes attachment.
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More recently, progress has been made toward high-
resolution 2D mapping of cell tractions at cell surface. 
Traction force microscopy (TFM) has been widely 
used to characterize single cardiomyocyte contractil-
ity [17], exploiting cardiomyocytes ability to wrinkle 
an elastic substrate during contraction. TFM consists 
on tracking displacements of nanobeads embedded 
on a hydrogel substrate. Knowing the mechanical 
characteristics of the substrate and using mathemati-
cal estimations TFM allows to quantify the traction 
stress exerted by contracting cells. The main advantage 
of TFM is that it is noninvasive, nonterminal and it 
only requires basic equipment to assess cardiomyocytes 
contractile performance. Video microscopy simplifies 
TFM by removing the need of beads embedded in the 
substrate: indeed, estimated strain fields of complex 
cell distortions rely on standalone high-quality image 
acquisition [18].
Another important challenge related to cardiac 
model generation has been the investigation of electro-
physiological characteristics of cultured cells. The abil-
ity of quantitatively assessing functional parameters 
such as spontaneous beating frequency, depolarization-
repolarization patterns and ionic currents magnitude 
is particularly appealing to drug screening and regen-
erative medicine applications. Different techniques 
are available to perform measurements of single cell 
 electrophysiological activity.
To monitor and directly measure extracellular 
potential of interconnected cellular monolayers in vitro, 
microarrays of electrode (MEAs) have been devel-
oped [19]. MEA technology consists of arrays of micro-
electrodes (made of indium tin oxide or titanium) 
patterned onto a glass surface that permits simulta-
neous stimulation and recording of extracellular field 
potentials generated by cell action potentials. Differ-
ent electrode patterns (from 8 × 8 up to 16 × 16 grid) 
can be achieved, allowing for recording signal with 
high spatial and temporal resolution. Conversely to 
patch clamp, the most prominent advantage of MEAs 
relies on the possibility to achieve long-term and non-
invasive monitoring of large cell population. For this 
reason, MEAs have been widely exploited to conduct 
safety pharmacology studies directly on monolayers 
of human-induced pluripotent stem cell derived car-
diomyocytes, monitoring real-time changes in cardiac 
action potential duration after drug administration [20]. 
In order to combine the long-term, noninvasive MEA 
measurements with the possibility to record intracel-
lular action potentials, protruding gold mushroom-
shaped microelectrodes were also developed [21]. This 
system allows the repeated intracellular recording of 
cardiomyocyte action potential after an electroporation 
pulse that temporarily disrupts the cell membrane.
All the above-mentioned technologies are efficient 
for single cells or interconnected cell monolayer elec-
trical measurements and were successfully integrated 
in standard 2D culture platforms. However there is an 
urgent need to integrate electrical measurement sys-
tems within advanced microfluidic platforms, where 
chemical and physical stimulations are tailored to gen-
erate in vitro complex cardiac models.
Integrating functional readouts in heart-on-
chips
Perspective heart-on-a-chip systems integrate strategies 
that allow quantitative functional analysis of cardiac 
tissue parameters. The major advantage of standalone 
microfluidic devices is that they do not require compli-
cated and potentially disruptive tissue manipulations, 
while continuously assessing cardiac functional read-
outs along the whole culture period.
In terms of contractility, muscular thin films (MTF) 
are 2D bilaminate engineered cultures that recapitulate 
tissue-scale cardiac contractile behavior. Cardiomyo-
cytes were cultured on deformable thin films that bend 
in response to the systolic stress generated. Recently, 
Lind et al. [22] upgraded the manufacturing procedure 
concept and used multimaterial 3D printing technique 
to fabricate an MTF-inspired heart-on-a-chip. Fully 
automated acquisition of twitch data was made pos-
sible by integrating soft strain gauge sensors within the 
device. Despite the high automation achieved, MTF 
strategy does not recapitulate the 3D complex native 
heart tissue organization. 
In microfluidic-based 3D cardiac tissue model con-
figurations, the main data acquisition obstacles are 
related to highly dense and tightly packed cell con-
figurations that make individual cell analysis chal-
lenging. Hence, systems aim at determining the over-
all mechanical properties of the bulk cardiac tissue. 
For instance, video-based methods were employed by 
Mathur et al. [23] to analyze time-averaged beating 
motion and beating kinetics of cardiac microphysiolog-
ical systems. In general, force quantification of the 3D 
cardiac constructs by video microscopy is likely to be 
affected by analysis conditions. Tissue anchors to bulky 
“…in order to fulfill the goal of stand-alone 
 platforms for high-throughput analyses of 
 cardiac models performances in basic research or 
drug screening, a deeper focus in the direction of 
integrating cardiac cells functional assessments is 
required. With a successful integration of  cardiac 
output measurement systems, the existing 
heart-mimicking microfluidic organs-on-chips are 
expected to pave the way to a new generation of 
in vitro testing capabilities.”
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walls of microdevice that withstand tissue contractions, 
making moving edges insignificant or undetectable.
In terms of electrical activity recordings, only a 
few studies report the integration of direct recording 
systems within heart-on-chip microfluidic platforms. 
Platinum electroplated planar electrodes in combina-
tion with microfluidic networks were used to measure 
extracellular potentials of single entrapped cardio-
myocytes during spontaneous contraction [24]. With a 
similar approach, patterned Ag/AgCl electrodes placed 
in two separate microchannels connected by cells are 
exploited to both stimulate and record cardiac action 
potential of single-cell or pairs of cardiomyocytes [25].
Microfluidic platforms integrating MEA surfaces 
have also been developed. Agarose microstructures or 
PDMS-based culture chambers developed on top of 
MEAs allow the precise control of spatial cell arrange-
ment, enabling investigations of cardiac electrical 
activity spatiotemporal development. This technique 
can be applied to record cardiomyocyte field potential 
fluctuations in response to drug administration [26], 
to assess cardiac modulation exerted by sympathetic 
nervous system [27] or to investigate conduction veloc-
ity and cellular physiological functionality after an 
ischemic event, testing the capabilities of different cell 
sources to form new gap junctions [28].
Noteworthy, none of the previously described meth-
ods (patch clamp or gold mushroom-shaped micro-
electrodes) allowing for assessing information on 
intracellular electric potential have yet been coupled to 
microfluidic platforms. Furthermore, none of the 3D 
in vitro cardiac microfluidic models include electrical 
activity recording systems.
Conclusion
The number of organs-on-chip focused on heart phys-
iology is continuously rising and ever more complex 
microenvironments are tailored for heart cells growth 
and analysis. The existing literature is widely focused 
on tailoring specific on-chip environmental cues, par-
ticularly electromechanical stimuli, to generate car-
diac biological models. However, in order to fulfill 
the goal of stand-alone platforms for high-through-
put analyses of cardiac models performances in basic 
research or drug screening, a deeper focus in the direc-
tion of integrating cardiac cells functional assessments 
is required. With a successful integration of cardiac 
output measurement systems, the existing heart-mim-
icking microfluidic organs-on-chips are expected to 
pave the way to a new generation of in vitro testing 
capabilities.
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